BRIGHT MINDS BIOSCIENCES INC. financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data BRIGHT MINDS BIOSCIENCES INC. files with the SEC in its annual reports.
In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2021
FY2022
FY2023
FY2024
Research and development
0.35
6.31
12.2
5
1.18
Income tax
0
0
0
0
0
Net income
-0.48
-8.65
-15
-7.37
-2.8
EPS, basic
-0.65
-4.82
-6.06
-1.98
-0.65
EPS, diluted
-0.65
-4.82
-6.06
-1.98
-0.65
Balance sheet
FY2021
FY2021
FY2022
FY2023
FY2024
Cash and equivalents
0.8
19.8
11.6
6.75
5.72
Total current assets
0.88
20
11.9
6.81
5.99
Lease right-of-use assets
0
0.14
0.07
0.12
Total assets
0.88
20
12.1
6.88
6.1
Accounts payable
0.15
0.64
1.4
0.21
0.45
Total current liabilities
0.64
1.47
0.28
0.53
Lease liabilities
0
0.07
0
0.04
Total liabilities
0.15
0.64
1.54
0.28
0.57
Retained earnings
-0.56
-9.21
-24.2
-31.5
-34.3
Total equity
0.73
19.4
10.5
6.6
5.54
Total liabilities and equity
0.88
20
12.1
6.88
6.1
Cash flow statement
FY2021
FY2021
FY2022
FY2023
FY2024
Net income
-0.48
-8.65
-15
-7.37
-2.8
Cash from operations
-0.29
-7.32
-13.6
-7.02
-1.85
Stock issued
1.01
27.7
Cash from financing
1.01
26.1
5.2
2.19
0.81
Exchange rate effect
0
0.22
0.26
-0.05
0.01
Net change in cash
0.72
18.7
-8.39
-4.83
-1.04
Key metrics
Worked out from the statements above. Latest values use fiscal 2024. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-43.2%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Total assets growth, 1y
-11.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-32.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
11.3x
Current assets / current liabilities.
Quick ratio
10.8x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
10.8x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
9.3%
Total liabilities / total assets.
Working capital
CA$5.5M
Current assets - current liabilities.
Per share
Metric
Value
How it is calculated
EPS, diluted
-CA$0.65
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-CA$0.65
Net income per basic share, as reported (split-adjusted).
Was BRIGHT MINDS BIOSCIENCES INC. profitable in fiscal 2024?
No. It reported a net loss of CA$2.8M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.